Results of a blind, randomized, placebo-controlled trial show feasibility and efficacy of adventitial progenitor cell transplantation in a swine model of reperfused myocardial infarction.
Event:
ESC Congress 2017
Topic:
Stem cells and cell therapy
Session:
Cardiac regeneration and repair